-
1دورية أكاديمية
المؤلفون: Staeger, Ramon, Martínez-Gómez, Julia M., Turko, Patrick, Ramelyte, Egle, Kraehenbuehl, Lukas, Del Prete, Valerio, Hasan Ali, Omar, Levesque, Mitchell P., Dummer, Reinhard, Nägeli, Mirjam C., Mangana, Joanna
المصدر: Cancers; Mar2024, Vol. 16 Issue 5, p854, 19p
مصطلحات موضوعية: PROTEIN kinase inhibitors, MITOGEN-activated protein kinases, MELANOMA, DISEASE management, ANTINEOPLASTIC agents, TREATMENT effectiveness, TERTIARY care, RETROSPECTIVE studies, MULTIVARIATE analysis, IMMUNE checkpoint inhibitors, LONGITUDINAL method, TUMOR classification, PROGRESSION-free survival, OVERALL survival, BRAIN tumors, CHEMICAL inhibitors
مصطلحات جغرافية: SWITZERLAND
-
2دورية أكاديمية
المؤلفون: Freiberger, Sandra N., Holzmann, David, Morand, Grégoire B., Hüllner, Martin, Levesque, Mitchell P., Dummer, Reinhard, Koelzer, Viktor H., Rupp, Niels J.
المصدر: Journal of Cancer Research & Clinical Oncology; Aug2023, Vol. 149 Issue 9, p5645-5653, 9p
مصطلحات موضوعية: TUMOR antigens, TESTIS tumors, GENE expression, NUCLEOTIDE sequencing, IMMUNE checkpoint inhibitors, MELANOMA
-
3دورية أكاديمية
المؤلفون: Burgermeister, Simon, Gabryś, Hubert S., Basler, Lucas, Hogan, Sabrina A., Pavic, Matea, Bogowicz, Marta, Martínez Gómez, Julia M., Vuong, Diem, Tanadini-Lang, Stephanie, Foerster, Robert, Huellner, Martin W., Dummer, Reinhard, Levesque, Mitchell P., Guckenberger, Matthias
المصدر: Frontiers in Oncology; 4/14/2022, Vol. 12, p1-9, 9p
مصطلحات موضوعية: IMMUNE checkpoint inhibitors, IPILIMUMAB, PROPORTIONAL hazards models, COMPUTED tomography
-
4دورية أكاديمية
المؤلفون: Amweg, Austeja, Tusup, Marina, Cheng, Phil, Picardi, Ernesto, Dummer, Reinhard, Levesque, Mitchell P., French, Lars E., Guenova, Emmanuella, Läuchli, Severin, Kundig, Thomas, Mellett, Mark, Pascolo, Steve
المصدر: RNA Biology; Jan2022, Vol. 19 Issue 1, p996-1006, 11p
مصطلحات موضوعية: BRAF genes, RNA editing, RNA modification & restriction, GENE therapy, RAS oncogenes, MELANOMA, TRANSCRANIAL magnetic stimulation
-
5دورية أكاديمية
المؤلفون: Tusup, Marina, Cheng, Phil F., Picardi, Ernesto, Raziunaite, Austeja, Dummer, Reinhard, Levesque, Mitchell P., French, Lars E., Guenova, Emmanuella, Kundig, Thomas M., Pascolo, Steve
المصدر: Non-Coding RNA; Mar2021, Vol. 7 Issue 1, p1-11, 11p
مصطلحات موضوعية: IMMUNE checkpoint inhibitors, IMMUNOTHERAPY, MAJOR histocompatibility complex, RNA editing, MELANOMA, URIDINE
-
6دورية أكاديمية
المؤلفون: Fässler, Mirjam, Diem, Stefan, Mangana, Joanna, Ali, Omar Hasan, Berner, Fiamma, Bomze, David, Ring, Sandra, Niederer, Rebekka, Cruz, Cristina del Carmen Gil, Shibayama, Christian Ivan Pérez, Krolik, Michal, Siano, Marco, Joerger, Markus, Recher, Mike, Risch, Lorenz, Güsewell, Sabine, Risch, Martin, Speiser, Daniel E., Ludewig, Burkhard, Levesque, Mitchell P.
المصدر: Journal for ImmunoTherapy of Cancer; 12/1/2019, Vol. 7 Issue 1, p1-12, 12p
مصطلحات موضوعية: IMMUNOGLOBULINS, CONSTRAINT-induced movement therapy, TUMOR-infiltrating immune cells, IMMUNE checkpoint inhibitors, BIOMARKERS, MELANOMA
-
7دورية أكاديمية
المؤلفون: Dimitriou, Florentia, Staeger, Ramon, Ak, Melike, Maissen, Matias, Kudura, Ken, Barysch, Marjam J., Levesque, Mitchell P., Cheng, Phil F., Dummer, Reinhard, Mangana, Joanna
المصدر: Cancers; Jun2021, Vol. 13 Issue 12, p2931, 1p
مصطلحات موضوعية: SURVIVAL, IMMUNE checkpoint inhibitors, ADRENOCORTICAL hormones, MELANOMA, RETROSPECTIVE studies, IMMUNOLOGICAL adjuvants, DESCRIPTIVE statistics, DRUG side effects, IMMUNOTHERAPY, PHARMACODYNAMICS, THERAPEUTICS
-
8دورية أكاديمية
المؤلفون: Hilbers, Marie-Luise1 (AUTHOR), Dimitriou, Florentia1 (AUTHOR), Lau, Peter2 (AUTHOR), Bhave, Prachi2 (AUTHOR), McArthur, Grant A.2 (AUTHOR), Zimmer, Lisa3 (AUTHOR), Kudura, Ken4 (AUTHOR), Gérard, Camille L.5 (AUTHOR), Levesque, Mitchell P.1 (AUTHOR), Michielin, Olivier5 (AUTHOR), Dummer, Reinhard1 (AUTHOR) reinhard.dummer@usz.ch, Cheng, Phil F.1 (AUTHOR), Mangana, Joanna1 (AUTHOR)
المصدر: European Journal of Cancer. Oct2021, Vol. 156, p149-163. 15p.
مصطلحات موضوعية: *SURVIVAL, *IMMUNE checkpoint inhibitors, *COMBINATION drug therapy, *CONFIDENCE intervals, *MELANOMA, *METASTASIS, *IPILIMUMAB, *BRAIN tumors, *CANCER patients, *DESCRIPTIVE statistics, *IMMUNOTHERAPY, *THERAPEUTICS